|

Rifaximin Clinical Trials

3 actively recruiting trials

Also known as: Alfa Normix®, Gastrobiotic, Trencedia, Xifaxan

Pipeline

Phase 3: 1

Top Sponsors

  • Tanta University1
  • I.M. Sechenov First Moscow State Medical University1
  • General Hospital of Shenyang Military Region1

Indications

  • Liver Disease2
  • Overt Hepatic Encephalopathy1
  • Bacterial Overgrowth Syndrome Small Bowel1
  • Hepatic Encephalopathy1
  • Heart Failure With Preserved Ejection Fraction1

Other3 trials

Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Phase 3
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
N/A
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.